| Christopher M Wirsing, DO | |
|
880 Eastport Centre Dr, Suite 200, Valparaiso, IN 46383-2909 | |
| (219) 464-0409 | |
| (219) 464-2376 |
| Full Name | Christopher M Wirsing |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 880 Eastport Centre Dr, Valparaiso, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104838309 | NPI | - | NPPES |
| 100209730A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 02000885A (Indiana) | Primary |
| Entity Name | Healthlinc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528262581 PECOS PAC ID: 7618929373 Enrollment ID: O20050210000929 |
News Archive
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.
Kaiser Health News staff writer Phil Galewitz writes: "If employers save money on health insurance because of the new health law, will they give their workers a raise? Absolutely, says a new report by the trustees of Social Security.
A national survey of acute and critical care nurses finds that measures to reduce unnecessary testing and treatments are increasingly being integrated into clinical practice, even though most respondents are not aware of the campaign behind the specific recommendations.
What is the mechanism of action of metal-based chemotherapy drugs (the most widely used for treating common cancers like testicular or ovarian cancer)? How can we improve their effect and reduce their toxicity? A new study combining experiments and theory has broadened our knowledge of the molecular mechanisms of these active drugs to help experimentalists devising increasingly effective drugs with fewer side effects.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher M Wirsing, DO 880 Eastport Centre Dr, Suite 200, Valparaiso, IN 46383-2909 Ph: (219) 464-0409 | Christopher M Wirsing, DO 880 Eastport Centre Dr, Suite 200, Valparaiso, IN 46383-2909 Ph: (219) 464-0409 |
News Archive
MetaStat, Inc., a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of cancer metastasis, as well as companion therapeutics to prevent systemic metastasis, today announced that it has changed its name from PhotoVoltaic Solar Cells, Inc. to MetaStat, Inc. effective April 9, 2012.
What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.
Kaiser Health News staff writer Phil Galewitz writes: "If employers save money on health insurance because of the new health law, will they give their workers a raise? Absolutely, says a new report by the trustees of Social Security.
A national survey of acute and critical care nurses finds that measures to reduce unnecessary testing and treatments are increasingly being integrated into clinical practice, even though most respondents are not aware of the campaign behind the specific recommendations.
What is the mechanism of action of metal-based chemotherapy drugs (the most widely used for treating common cancers like testicular or ovarian cancer)? How can we improve their effect and reduce their toxicity? A new study combining experiments and theory has broadened our knowledge of the molecular mechanisms of these active drugs to help experimentalists devising increasingly effective drugs with fewer side effects.
› Verified 2 days ago
Maria O. Sacris, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2000 Roosevelt Rd, Ste 207, Valparaiso, IN 46383 Phone: 219-462-4042 Fax: 219-462-1444 | |
Elizabeth A Rutherford, MD FACOG Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 85 East Us Highway 6, Suite 330, Valparaiso, IN 46383 Phone: 219-462-6144 Fax: 219-465-1150 | |
Dr. Frank Ludwig Behrend, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2208 Wynnewood Dr, Valparaiso, IN 46385 Phone: 219-464-2955 | |
Kurt Alan Wiese, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 401 Wall St, Suite B, Valparaiso, IN 46383 Phone: 219-462-7773 Fax: 219-531-5988 | |
Crystal A Strickland, MD FACOG Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 85 East Us Highway 6, Suite 330, Valparaiso, IN 46383 Phone: 219-462-6144 Fax: 219-465-1150 | |
Dr. Amy Renee Rouse-ho, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2600 Roosevelt Rd Ste 200-6, Valparaiso, IN 46383 Phone: 219-615-0095 Fax: 317-350-1379 |